Roszdravnadzor-2021-0059-V059
Type II variation for application Roszdravnadzor-2021-0059. Type II variation: New Dosage Strength for Atezolimumab-R — critical change
Variation Number
Roszdravnadzor-2021-0059-V059
Type
Type II
Application
Change
Status
Draft
Fee
€17,508
Submitted
2022-08-24
Approved
—
Description
Type II variation: New Dosage Strength for Atezolimumab-R — critical change